FDA also accredited the FoundationOne®CDx assay to be a companion diagnostic unit to identify sufferers with breast cancer for treatment method with capivasertib with fulvestrant. CAPIVASERTIB (kap EYE va SER tib) treats breast cancer. It works by blocking a protein that triggers cancer cells to develop and multiply. This helps https://lordj666xit8.blogdun.com/profile